Openbookopenbook
Equity
Boston Scientific Corp.(0HOY)
USD --+0.00%
Reward73High
Risk41Moderate
📊75%Data
Strong 17% profit margin · Revenue growing 12% YoY
0HOY
+0.0 · +0.00%
USD · LSE
Boston Scientific Corp. |
Quality Compounder
Market Cap:—
ℹ️
Reward Rating
73
High
Top 25% (model universe)
75% data coverage
ℹ️
Risk Rating
41
Moderate
Risk Assessment
ℹ️

Educational tool only – Scores are based on historical data and financial metrics for informational purposes. This is not financial advice or a recommendation to buy or sell any security. Always conduct your own research or consult a qualified financial adviser.

ℹ️ Educational tool only · More
Limited data coverage
We don't have enough public data on 0HOY to score it reliably yet — Reward, Risk, Forecasts and Dividends tabs aren't available for this stock. The price chart and basic profile are still shown.
OTC / ADR stock — scores and fundamentals use data tagged in USD by our provider. The issuer may report in a different home currency (e.g. JPY), so treat figures as directional rather than precise.
Not available for limited-coverage stocks
The overview tab requires fundamentals and price history we don't have for this stock. The price chart is the most reliable view we have — try the Chart tab.

Market Performance

Stock returned +10.0% over the past year, broadly in line with market conditions.

What is Boston Scientific Corp.?

Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide.

0HOY · Verdict

Strong reward · moderate risk

0HOY stands out on profitability and growth, but watch the balance sheet signal.

Based on 88% data coverage

0HOY · Verdict

What’s working & what to watch

Strengths 4

  • Profitability88/100

    14% net margin · 12% ROE

  • Growth87/100

    Rev +16.5% CAGR · earnings +60.5%

  • Cash flow85/100

    18% free-cash-flow margin

  • Volatility65/100

    Above average

Watchouts 1

  • Balance sheet43/100

    Net debt/EBITDA 2.8×

Model-based scoring. For information only — not financial advice.

What is Boston Scientific Corp.?

Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. The company operates in two segments, MedSurg and Cardiovascular. The company is listed on the LSE in UK, and a P/E ratio of 1.1x.

Financial Highlights

Investment Breakdown

📈 Growth
Revenue and earnings growing steadily, indicating improving operating performance.
💰 Profitability
Strong margins and consistent earnings support financial stability.
⚠️ Risk
Risk profile appears balanced versus broad market conditions.
💸 Valuation
Valuation appears fair relative to current fundamentals.

OpenBook Logo Analysis

Reward: High (73)

The scoring profile indicates a strong reward potential, driven primarily by profitability and growth. Risk indicators are moderate, consistent with typical market exposure.

For informational purposes only. Not financial advice.

Company Information
SectorN/A
Market CapN/A
P/E Ratio1.0781
Dividend YieldN/A
52 Week High109.507
52 Week Low56.18
Last AnnualDecember
IPO DateN/A
IncorporatedUK
Shares Outstanding1B
No. of Employees59,000
IndustryN/A
ExchangeLSE
Beta0.782
CurrencyUSD
Websitewww.bostonscientific.com
openbook

Stock research for everyday UK investors. Make smarter decisions, faster.

Questions? Email us at contact@openbookanalytics.com

© 2026 Openbook Analytics Ltd · Company No. SC843579 · Registered in Scotland

256-bit encryption GDPR compliant UK data centres

Openbook Analytics Ltd (Company No. SC843579) is registered in Scotland. Registered office: Strathclyde Inspire Hub, University of Strathclyde, Graham Hills Building (Level 6), 50 Richmond Street, Glasgow, G1 1XP. Openbook Analytics is not authorised or regulated by the Financial Conduct Authority (FCA). The content on this platform is provided for general informational and educational purposes only and does not constitute financial advice, investment advice, trading advice, or any other form of advice. You should not treat any content on this platform as a recommendation to buy, sell, or hold any financial instrument. Past performance is not a reliable indicator of future results. The value of investments and the income from them can go down as well as up, and you may get back less than you invest. User-generated content, including community posts and commentary, reflects the personal opinions of individual users, is not verified for accuracy, and does not represent the views of Openbook Analytics Ltd. You should always conduct your own research or consult a qualified, FCA-regulated financial adviser before making investment decisions. Data displayed on this platform may be delayed or inaccurate and is provided "as is" without warranty. Openbook Analytics Ltd accepts no liability for any loss arising from reliance on the information provided.